search
Back to results

Investigating Modes of Progressive Mobility

Primary Purpose

Critical Care, Mechanical Ventilation, Intensive Care

Status
Completed
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
ETM protocol
Sponsored by
Hill-Rom
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Critical Care focused on measuring therapeutic mobility, acute care, nursing, inflammatory markers

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • P:F ratio > 100
  • FiO2 < 60% and PEEP less than 10 cmH20
  • hemodynamic stability ten minutes after turning (i.e., heart rate (HR) and/or systolic blood pressure (BP) changes less than 20% of baseline)
  • baseline (rest) vitals signs of HR 50-110
  • mean arterial pressure (MAP) 60-100 mmHg
  • peripheral oxygenation saturation (SpO2) greater than 88%
  • Sufficient cognition for progression to levels 2-4 of ETM to assist with out of bed positioning or movement
  • a high degree of dependency on others for positioning is acceptable
  • there are no exclusions based on gender or minority status.

Exclusion Criteria:

  • End-stage muscular dystrophy
  • myasthenia gravis
  • new quadriplegia
  • coma
  • increased intracranial pressure
  • unrepaired hip fracture and multiple lower extremity fractures
  • Patients experiencing active titration of intravenous vasoactive medications (e.g. dopamine, epinephrine, or norepinepherine) will be excluded
  • concurrent use of a continuous lateral rotation bed
  • patients for high risk of death will also be excluded
  • MICU admission following a hospital stay of >9 days in the past months
  • age >80 in the presence of 2 or more life-threatening illnesses
  • diagnosis of an active stage IV malignancy
  • status post cardiac arrest
  • diagnosis of intracerebral hemorrhage requiring mechanical ventilation
  • subjects over 400 pounds can be excluded from mobilization based on the judgment of the bedside nurse or project manager; if the risk for staff or patient harm from moving a patient with excessive weight is considered likely, mobilization will not occur.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    No Intervention

    Experimental

    Arm Label

    1

    2

    Arm Description

    RA begins data collection with chart review for demographic and explanatory variables, collects data for baseline muscle strength. During standard care period, PM will obtain information about the plan for activity for enrolled patients (turning, complete or partial weight-bearing i.e., reverse Trendelenberg positioning, ROM, sitting and walking) through discussion with the direct providers. RA will interview one provider about factors which influence the decision to implement activity or provide bedrest, including the presence of orders for bedrest or physical therapy. If activity is planned, the PM will observe and record the type and duration of activity, drawing serum biomarkers 20 minutes before and 20 minutes after the activity. If no activity is planned or activity duration is less than 10 minutes, serum for only baseline inflammatory biomarkers will be drawn. The RA will collect outcomes data within 24 hours of discharge from the ICU.

    Identical procedures for date recruitment, consent and data collection will occur. In this phase, the Project Manager will promote the use of the ETM protocol through coaching (e.g., reminding staff of benefits of mobility, identification of available resources, or suggesting cessation of bedrest orders) and by participating in planning at least one 20-minute activity.

    Outcomes

    Primary Outcome Measures

    Compare immediate molecular and physiological patient responses to activity with responses to an ETM protocol.

    Secondary Outcome Measures

    A secondary aim is to identify strategies and conditions that promote or prevent ETM.

    Full Information

    First Posted
    November 6, 2008
    Last Updated
    July 2, 2009
    Sponsor
    Hill-Rom
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00787098
    Brief Title
    Investigating Modes of Progressive Mobility
    Official Title
    Investigating Modes of Progressive Mobility
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2009
    Overall Recruitment Status
    Completed
    Study Start Date
    November 2007 (undefined)
    Primary Completion Date
    April 2009 (Actual)
    Study Completion Date
    July 2009 (Actual)

    3. Sponsor/Collaborators

    Name of the Sponsor
    Hill-Rom

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose of this study is to compare the effects of specific activities with and without an early therapeutic mobility (ETM) protocol among patients who experience three or more days of mechanical ventilation. A second purpose is to examine staff/delivery system and patient factors that influence the initiation and progression of activity with and without an ETM protocol. The hypothesis is that ETM protocols will result in improved patient outcomes.
    Detailed Description
    The specific aims of this study are to: Compare patient responses to selected modes of therapy (activity) without and with an ETM protocol Molecular responses: markers of inflammation interleukin (IL)-6 and IL-10 Physiological responses: peripheral oxygen saturation, heart rate, blood pressure, new dysrhythmias Safety/Unsafe events including pain, fatigue, line or tube dislodgement, fall or near fall Determine the associations between duration and level of activity/ETM achieved and outcomes: occurrence of delirium occurrence of ventilator associated pneumonia occurrence of deep vein thrombosis or pulmonary emboli occurrence of acquired pressure ulcer muscle strength number of days mechanically ventilated discharge location (after ICU) Describe strategies used in the ICU to initiate and implement activity with and without an ETM protocol use of personnel such as registered nurses, physical therapists, respiratory therapist and nursing assistants use of equipment such as a walker, lift device, belt or bed perception of sufficient time and abilities Describe patient factors that are associated with implementation of ETM Potentially modifiable exemplars: sedation, site of vascular access, physician orders Potentially nonmodifiable exemplars: weight, consciousness, hemodynamic instability, terminal condition This is a prospective, longitudinal, repeated measures study with a control period, run-in period and intervention period. Data will be collected during all three periods for comparison. During the control period, patients will receive standard care. Standard care in this institution does not include a program of progressive or early mobility but does include activities similar to the ETM protocol, implemented at the discretion of the staff. During the run-in period, subjects will receive a mix of standard care and the intervention.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Critical Care, Mechanical Ventilation, Intensive Care, Muscular Atrophy
    Keywords
    therapeutic mobility, acute care, nursing, inflammatory markers

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 2
    Interventional Study Model
    Crossover Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    82 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    1
    Arm Type
    No Intervention
    Arm Description
    RA begins data collection with chart review for demographic and explanatory variables, collects data for baseline muscle strength. During standard care period, PM will obtain information about the plan for activity for enrolled patients (turning, complete or partial weight-bearing i.e., reverse Trendelenberg positioning, ROM, sitting and walking) through discussion with the direct providers. RA will interview one provider about factors which influence the decision to implement activity or provide bedrest, including the presence of orders for bedrest or physical therapy. If activity is planned, the PM will observe and record the type and duration of activity, drawing serum biomarkers 20 minutes before and 20 minutes after the activity. If no activity is planned or activity duration is less than 10 minutes, serum for only baseline inflammatory biomarkers will be drawn. The RA will collect outcomes data within 24 hours of discharge from the ICU.
    Arm Title
    2
    Arm Type
    Experimental
    Arm Description
    Identical procedures for date recruitment, consent and data collection will occur. In this phase, the Project Manager will promote the use of the ETM protocol through coaching (e.g., reminding staff of benefits of mobility, identification of available resources, or suggesting cessation of bedrest orders) and by participating in planning at least one 20-minute activity.
    Intervention Type
    Other
    Intervention Name(s)
    ETM protocol
    Intervention Description
    ETM is 4 levels. Level 1, each receives repositioning from lateral to supine positions at even hours, totaling 60 minutes of activity/positioning over 24 hours. If tolerated, two periods of 20 minutes of supine position with a reverse trendelenberg position of 15-20 degrees will be used to promote orthostasis. Level 2 is turning every 2 hours, positioning in reverse trendelenberg at 15-25 degrees as tolerated, active resistance with ICU staff for 20 minutes daily for a total of 60-80 minutes of activity/positioning daily. At Level 3, 2 times 20 minutes of a sitting are added to active ROM and inbed turning (estimated 80-100 total minutes of activity daily). Sitting is in bed or with non-weightbearing assisted transfer to chair with backrest elevation at 75-90 degrees and legs in a dependent position. Level 3 interventions; minimal weight-bearing. Level 4, weight-bearing transfer to chair and ambulation are added to inbed turning.
    Primary Outcome Measure Information:
    Title
    Compare immediate molecular and physiological patient responses to activity with responses to an ETM protocol.
    Time Frame
    1, 2, 3, 7, days then weekly
    Secondary Outcome Measure Information:
    Title
    A secondary aim is to identify strategies and conditions that promote or prevent ETM.
    Time Frame
    1, 3, 5, 7, days then weekly

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: P:F ratio > 100 FiO2 < 60% and PEEP less than 10 cmH20 hemodynamic stability ten minutes after turning (i.e., heart rate (HR) and/or systolic blood pressure (BP) changes less than 20% of baseline) baseline (rest) vitals signs of HR 50-110 mean arterial pressure (MAP) 60-100 mmHg peripheral oxygenation saturation (SpO2) greater than 88% Sufficient cognition for progression to levels 2-4 of ETM to assist with out of bed positioning or movement a high degree of dependency on others for positioning is acceptable there are no exclusions based on gender or minority status. Exclusion Criteria: End-stage muscular dystrophy myasthenia gravis new quadriplegia coma increased intracranial pressure unrepaired hip fracture and multiple lower extremity fractures Patients experiencing active titration of intravenous vasoactive medications (e.g. dopamine, epinephrine, or norepinepherine) will be excluded concurrent use of a continuous lateral rotation bed patients for high risk of death will also be excluded MICU admission following a hospital stay of >9 days in the past months age >80 in the presence of 2 or more life-threatening illnesses diagnosis of an active stage IV malignancy status post cardiac arrest diagnosis of intracerebral hemorrhage requiring mechanical ventilation subjects over 400 pounds can be excluded from mobilization based on the judgment of the bedside nurse or project manager; if the risk for staff or patient harm from moving a patient with excessive weight is considered likely, mobilization will not occur.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Chris Winkelman, PhD
    Organizational Affiliation
    Case Western Reserve University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    18596631
    Citation
    Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, Ross A, Anderson L, Baker S, Sanchez M, Penley L, Howard A, Dixon L, Leach S, Small R, Hite RD, Haponik E. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med. 2008 Aug;36(8):2238-43. doi: 10.1097/CCM.0b013e318180b90e.
    Results Reference
    background

    Learn more about this trial

    Investigating Modes of Progressive Mobility

    We'll reach out to this number within 24 hrs